Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Positive efficacy results reported in phase 3 study of schizophrenia injectable
Teva Pharmaceuticals and Medincell have announced positive efficacy results from the phase 3 SOLARIS clinical trial evaluating an investigational, monthly subcutaneous injectable in adults with schizophrenia.
Osteoarthritis may be 'inherently' tied to neuroplasticity
DESTIN, Fla. — “Sprouting” of new nerve endings in certain areas of the knee could be a key to understanding osteoarthritis and developing new treatments, according to a speaker at the Congress of Clinical Rheumatology East.
Log in or Sign up for Free to view tailored content for your specialty!
FDA grants orphan drug designation to biologic therapy for Angelman syndrome
The FDA has granted orphan drug designation to a microbiome-modifying biologic to treat Angelman syndrome, according to the manufacturer.
Migraine, GI symptoms increase risk of adverse psychiatric comorbidities
DENVER — For those diagnosed with migraine, gastrointestinal issues or both, psychiatric comorbidities increase the risk of worsened physical and mental states, according to an expert at the American Academy of Neurology annual meeting.
Physician practice owners need to review key financial data points regularly
A physician practice owner’s week is spent seeing and caring for patients and managing the day-to-day issues of the practice.
Neurologists mired in ‘wait and see’ approach to Leqembi prescription, administration
The FDA’s approval of Leqembi in July 2023 triggered a wave of discussion in the medical community on how to prescribe and properly administer the amyloid-targeting antibody to treat those diagnosed with Alzheimer’s disease.
Lidocaine injection linked to increased pain relief in youths with acute migraine
DENVER — Lidocaine injection in the occipital region for young persons with acute migraine significantly increased pain relief compared with saline injections, according to research presented at the American Academy of Neurology annual meeting.
Topcon, Microsoft partner to create AI-powered ‘Healthcare from the Eye’ prescreening tool
Topcon Healthcare has partnered with Microsoft Corp. to create “Healthcare from the Eye,” an AI-powered solution developed to improve health care by prescreening patients for systemic and neurological diseases via a noninvasive eye scan.
FDA grants breakthrough therapy designation to myotonic dystrophy type 1 drug
The FDA has granted breakthrough therapy designation to a proprietary oligonucleotide conjugate for the treatment of myotonic dystrophy type 1, according to the manufacturer.
Surgical intervention linked to better outcomes at 180 days for intracerebral hemorrhage
For patients diagnosed with intracerebral hemorrhage, surgical intervention within 24 hours led to better functional outcomes at 180 days compared with medical management alone, researchers wrote in the New England Journal of Medicine.
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read